Screener
Eton Pharmaceuticals, Inc. ETON Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | Three months ended / March 31, 2026 | Three months ended / March 31, 2025 |
|---|---|---|
| Accrued Medicaid rebates | 1,824 | 6,071 |
| Accrued liabilities | (1,532) | (1,373) |
| Other non-current assets and liabilities | (1,818) | 2,191 |
| Net cash from operating activities | 7,405 | 2,090 |
| Cash flows used in investing activities | ||
| Purchases of product license rights | (15,000) | — |
| Purchases of property and equipment | (75) | — |
| Net cash used in investing activities | (15,075) | — |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s operating cash flow?
- Eton Pharmaceuticals, Inc. (ETON) reported operating cash flow of $7.41M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Eton Pharmaceuticals, Inc.'s operating cash flow increased by 254.3% year-over-year, from $2.09M to $7.41M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Eton Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude